Dr Elsa Solaris is a synthetic biologist, bio-futurist and science fiction writer.
Elsa is a former venture capital investor and scientist who helped build and launch over two dozen life sciences startups to transform the food, health, and tech industries as a program director at SOSV, the most active global early-stage fund.
BBC, New Statesman, deVolkskrant, Arab News, TedX, RedBull Media, and others have featured her work as a popular futurist speaker. Silicon Republic recognises Elsa as leading woman in biotech.
She speaks five languages, has lived in nine countries and holds a PhD in synthetic biology from Imperial College London and the University of Hong Kong, for which she won a merit-based scholarship to develop cancer-fighting biological nanobots.
Solaris now manages her investment portfolio, appears as a keynote speaker worldwide, consults F100 companies and writes speculative fiction.
She has published short stories, poetry and art, participated in the BBC’s award-winning Sci-Fi Thriller Podcast ‘Forest 404′, and won an honourable mention at Writers of the Future in Hollywood, L.A.
Recently, she made the Young Storyteller Award Top 20 by ‘story.one’ publishing and book retailer Thalia (out of 1200) with her new book.
What is a Bio-Futurist?
As a Bio-Futurist, Elsa helps others understand how emerging (bio)technologies will change our lives.
She uses her visionary science fiction mindset to accelerate disruptive business innovation.
The Biofuturist’s mission is to help companies use science fiction prototyping to create products that solve tomorrow’s problems.
Bio-Futurist Keynote Speaker:
Elsa is an experienced keynote speaker and innovation consultant on the disruption between biology and technology.
She delivers bespoke presentations and workshops for corporate and public events:
Speaking topics include:
- The Digital Biology Revolution – Dystopia or Utopia?
- Human Augmentation: How we are biohacking our relationship with love, death and our own evolution.
- From Sci-Fi to Reality: How companies can unleash moonshot thinking for disruptive innovation.